We’ve moved

The Rosalind and Morris Goodman Cancer Institute can now be found at www.goodmancancer.ca

Visit the new site

 

Home

Open Science project funded for $1.5M

Published: 12 November 2024

YCharOS antibody characterization platform addresses the “reproducibility crisis” in research...

Genetic sequencing project receives more than $8 million in funding

Published: 18 March 2025

NeuRo Genomics Initiative will help better understand rare and aging-related neurological disorders affecting Canadians...

Latest Alzheimer’s drug shown less effective in females than males

Published: 18 March 2025

Since becoming only the second Alzheimer’s-modifying drug to gain American FDA approval in 2023, sales of lecanemab, known by its brand name Leqembi, have risen steadily, reaching $87-million USD...

Six principal investigators from The Neuro receive CIHR grants

Published: 10 February 2025

Projects include important research on Parkinson’s, glioblastoma and dementia  

AI analysis of healthcare records reveals key factors in autism diagnosis

Published: 26 March 2025

Scientists argue the criteria we use for diagnosing autism may need revision...

An open solution to improving research reproducibility

Published: 18 December 2024

Academic and industry scientists collaborate on a new method to characterize research antibodies

Celebrating 45 years of Making Discoveries and Changing Lives at the GCI

Friday, February 3, 2023 16:00to19:00

For WORLD CANCER DAY, join us to celebrate our legacy, discover the beauty of science through the lens of our trainees, and enjoy some refreshments!...

GCI Spotlight - Chu-Han Feng

Friday, November 25, 2022 16:00to17:00

Presenter: Chu-Han Feng When: Friday November 25th, 4pm Where: GCI 5th floor atrium/gciCategory: Academic conferences and symposia Academic seminars and lectures Academic talks and conferences

Pages

Subscribe to Undergraduate Students RSS
Back to top